litlas
ログインアカウント作成

Michael A. Morse

1995–2025 年に発表

別表記
Michael A Morse
129
論文数
25,504
被引用数
84
h 指数
124
i10 指数

被引用数

Michael A. Morse の年別被引用数1996 年: 被引用 1 件1997 年: 被引用 2 件1998 年: 被引用 2 件1999 年: 被引用 8 件2000 年: 被引用 24 件2001 年: 被引用 39 件2002 年: 被引用 35 件2003 年: 被引用 59 件2004 年: 被引用 59 件2005 年: 被引用 52 件2006 年: 被引用 71 件2007 年: 被引用 66 件2008 年: 被引用 92 件2009 年: 被引用 156 件2010 年: 被引用 140 件2011 年: 被引用 147 件2012 年: 被引用 141 件2013 年: 被引用 131 件2014 年: 被引用 151 件2015 年: 被引用 152 件2016 年: 被引用 173 件2017 年: 被引用 256 件2018 年: 被引用 351 件2019 年: 被引用 987 件2020 年: 被引用 1,339 件2021 年: 被引用 1,299 件2022 年: 被引用 982 件2023 年: 被引用 786 件2024 年: 被引用 1,134 件2025 年: 被引用 552 件2026 年: 被引用 11 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,246 件、この内訳の 25.4%中国: 引用元論文 1,886 件、この内訳の 14.8%イタリア: 引用元論文 749 件、この内訳の 5.9%ドイツ: 引用元論文 655 件、この内訳の 5.1%イギリス: 引用元論文 601 件、この内訳の 4.7%フランス: 引用元論文 589 件、この内訳の 4.6%スペイン: 引用元論文 441 件、この内訳の 3.5%日本: 引用元論文 406 件、この内訳の 3.2%カナダ: 引用元論文 325 件、この内訳の 2.5%オランダ: 引用元論文 325 件、この内訳の 2.5%オーストラリア: 引用元論文 287 件、この内訳の 2.3%韓国: 引用元論文 259 件、この内訳の 2%
0%25.4%その他 23.5%

機関

分野

  • Medicine62.6%
  • Biochemistry, Genetics and Molecular Biology21.8%
  • Immunology and Microbiology11.8%
  • Engineering1.8%
  • Neuroscience0.4%
  • Materials Science0.4%
  • その他1.2%

トピック

  • Cancer Immunotherapy and Biomarkers10.5%
  • Immunotherapy and Immune Responses6%
  • Colorectal Cancer Treatments and Studies3.7%
  • Extracellular vesicles in disease3.3%
  • CAR-T cell therapy research3.1%
  • Genetic factors in colorectal cancer2.6%
  • その他70.8%

共著者

全論文

検索で開く
  1. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

    著者: Michael J. Overman, Ray McDermott, Joseph L. Leach, Sara Lonardi, Heinz‐Josef Lenz, Michael A. Morse, Jayesh Desai, Andrew Hill, Michael D. Axelson, Rebecca A. Moss, Monica V. Goldberg, Z. Alexander Cao, Jean-Marie Ledeine, Gregory A. Maglinte, Scott Kopetz, Thierry André - The Lancet Oncology 2017 被引用: 2,816

  2. Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer

    著者: Michael J. Overman, Sara Lonardi, Ka Yeung Mark Wong, Heinz‐Josef Lenz, Fabio Gelsomino, Massimo Aglietta, Michael A. Morse, Eric Van Cutsem, Ray McDermott, Andrew Hill, Michael B. Sawyer, Alain Hendlisz, Bart Neyns, Magali Svrcek, Rebecca A. Moss, Jean-Marie Ledeine, Z. Alexander Cao, Shital Kamble, Scott Kopetz, Thierry André - Journal of Clinical Oncology 2018 被引用: 2,070

  3. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

    著者: Michael A. Morse, Jennifer Garst, Takuya Osada, Shubi Khan, Amy Hobeika, Timothy M. Clay, Nancy Valente, Revati Shreeniwas, Mary Ann Sutton, Alain Delcayre, Di‐Hwei Hsu, Jean‐Bernard Le Pecq, H. Kim Lyerly - Journal of Translational Medicine 2005 被引用: 1,115

  4. Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians

    著者: Dimitrios Moris, Manisha Palta, Charles Kim, Peter J. Allen, Michael A. Morse, Michael E. Lidsky - CA A Cancer Journal for Clinicians 2022 被引用: 468

  5. Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial

    著者: Scott Antonia, José A. López-Martín, Johanna C. Bendell, Patrick A. Ott, Matthew H. Taylor, Joseph P. Eder, Dirk Jäger, M. Catherine Pietanza, Dung T. Le, Filippo de Braud, Michael A. Morse, Paolo A. Ascierto, Leora Horn, Asim Amin, Rathi N. Pillai, Jeffry Evans, Ian Chau, Petri Bono, Akin Atmaca, Padmanee Sharma, Christopher Harbison, Chen-Sheng Lin, Olaf Christensen, Emiliano Calvo - The Lancet Oncology 2016 被引用: 1,254

  6. Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142

    著者: Thierry André, Sara Lonardi, Ka Yeung Mark Wong, H.J. Lenz, Fabio Gelsomino, Massimo Aglietta, Michael A. Morse, Eric Van Cutsem, Ray McDermott, Andrew Hill, Michael B. Sawyer, Alain Hendlisz, Bart Neyns, Sandzhar Abdullaev, Arteid Memaj, Ming Lei, Michael F. Dixon, Scott Kopetz, Michael J. Overman - Annals of Oncology 2022 被引用: 253

  7. The Role of Angiogenesis in Hepatocellular Carcinoma

    著者: Michael A. Morse, Weijing Sun, Richard D. Kim, Aiwu Ruth He, Paolo Abada, Michelle Mynderse, Richard S. Finn - Clinical Cancer Research 2018 被引用: 546

  8. Vaccine Therapies for Cancer: Then and Now

    著者: Michael A. Morse, William R. Gwin, Duane A. Mitchell - Targeted Oncology 2021 被引用: 214

  9. Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer

    著者: Dung T. Le, Andrea Wang‐Gillam, Vincent J. Picozzi, Tim F. Greten, Todd S. Crocenzi, Gregory M. Springett, Michael A. Morse, Herbert J. Zeh, Deirdre Jill Cohen, Robert L. Fine, Beth Onners, Jennifer N. Uram, Daniel A. Laheru, Eric R. Lutz, Sara Solt, Aimee Murphy, Justin Skoble, Ed Lemmens, John Grous, Thomas W. Dubensky, Dirk G. Brockstedt, Elizabeth M. Jaffee - Journal of Clinical Oncology 2015 被引用: 600

  10. Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

    著者: Christine H. Chung, Beloo Mirakhur, Emily Chan, Quynh‐Thu Le, Jordan Berlin, Michael A. Morse, Barbara A. Murphy, Shama M. Satinover, Jacob D. Hosen, David Mauro, Robbert J.C. Slebos, Qinwei Zhou, Diane R. Gold, Tina Hatley, Daniel J. Hicklin, Thomas A.E. Platts‐Mills - New England Journal of Medicine 2008 被引用: 1,483

  11. Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)

    著者: Dung T. Le, Vincent J. Picozzi, Andrew H. Ko, Zev A. Wainberg, Hedy L. Kindler, Andrea Wang‐Gillam, Paul E. Oberstein, Michael A. Morse, Herbert J. Zeh, Colin D. Weekes, Tony Reid, Erkut Borazanci, Todd S. Crocenzi, Noelle K. LoConte, Benjamin Musher, Dan Laheru, Aimee Murphy, Chan C. Whiting, Nitya Nair, Amanda Enstrom, Sandy Ferber, Dirk G. Brockstedt, Elizabeth M. Jaffee - Clinical Cancer Research 2019 被引用: 261

  12. Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 mg/kg Plus Ipilimumab 3 mg/kg Expansion Cohort Results

    著者: Padmanee Sharma, Arlene O. Siefker‐Radtke, Filippo de Braud, Umberto Basso, Emiliano Calvo, Petri Bono, Michael A. Morse, Paolo A. Ascierto, José A. López-Martín, Peter Brossart, Kristoffer Staal Rohrberg, Begoña Mellado, Bruce S. Fischer, S. Meadows–Shropshire, Abdel Saci, Margaret K. Callahan, Jonathan E. Rosenberg - Journal of Clinical Oncology 2019 被引用: 243

  13. Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)

    著者: Li-Chung Tsao, John S. Wang, Xingru Ma, Sirajbir Sodhi, Joey V. Ragusa, Bushangqing Liu, Jason McBane, Tao Wang, Jun-Ping Wei, Cong-Xiao Liu, Xiao Yang, Gangjun Lei, Ivan Spasojević, Ping Fan, Timothy N. Trotter, Michael A. Morse, H. Kim Lyerly, Zachary C. Hartman - Nature Communications 2025 被引用: 104

  14. Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets

    著者: Benjamin A. Weinberg, Joanne Xiu, Michael Lindberg, Anthony F. Shields, Jimmy J. Hwang, Kelsey Poorman, Mohamed E. Salem, Michael J. Pishvaian, Randall F. Holcombe, John Marshall, Michael A. Morse - Journal of Gastrointestinal Oncology 2019 被引用: 183

  15. 1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 Study

    著者: Ralph Stephan von Bardeleben, Paul Mahoney, Michael A. Morse, Matthew J. Price, Paolo Denti, Francesco Maisano, Jason H. Rogers, Michael Rinaldi, Federico De Marco, William Rollefson, Bassem Chehab, Mathew Williams, Guillaume Leurent, Federico M. Asch, Evelio Rodríguez - JACC: Cardiovascular Interventions 2023 被引用: 124

  16. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity

    著者: Shinya Abe, Hiroshi Nagata, Erika J Crosby, Yoshiyuki Inoue, Kensuke Kaneko, Cong-Xiao Liu, Xiao Yang, Tao Wang, Chaitanya R Acharya, Pankaj Agarwal, Joshua Snyder, William Gwin, Michael A Morse, Pei Zhong, Herbert Kim Lyerly, Takuya Osada - Journal for ImmunoTherapy of Cancer 2022 被引用: 74

  17. Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium

    著者: Talal El Zarif, Amin H. Nassar, Elio Adib, Bailey G. Fitzgerald, Jiaming Huang, Tarek H. Mouhieddine, P Rubinstein, Taylor K. Nonato, Rana R. McKay, Mingjia Li, Arjun Mittra, Dwight H. Owen, Robert A. Baiocchi, Michael Lorentsen, Christopher Dittus, Nazlı Dizman, Adewunmi Falohun, Noha Abdel‐Wahab, Adi Diab, Anand Bankapur, Alexandra Reed, Chul Kim, Aakriti Arora, Neil J. Shah, Edward El‐Am, Elie Kozaily, Wassim Abdallah, Ahmad Al‐Hader, Batool Abu Ghazal, Anwaar Saeed, Claire Drolen, Melissa G. Lechner, Alexandra Drakaki, Javier Baena, Caroline A. Nebhan, Tarek Haykal, Michael A. Morse, Alessio Cortellini, David J. Pinato, Alessia Dalla Pria, Evan Hall, Veli Bakalov, Nathan Bahary, Aarthi Rajkumar, Ankit Mangla, Vishal Shah, Parminder Singh, Frank Aboubakar Nana, Nerea Lopetegui‐Lia, Danai Dima, Ryan W. Dobbs, Pauline Funchain, Rabia Saleem, Rachel Woodford, Georgina V. Long, Alexander M. Menzies, Carlo Genova, Giulia Barletta, Sonam Puri, Vaia Florou, Damé Idossa, Maristella Saponara, Paola Queirolo, Giuseppe Lamberti, Alfredo Addeo, Melissa Bersanelli, Dory Freeman, Wanling Xie, Erin Reid, Elizabeth Y. Chiao, Elad Sharon, Douglas B. Johnson, Ramya Ramaswami, Mark Bower, Brinda Emu, Thomas U. Marron, Toni K. Choueiri, Lindsey R. Baden, Kathryn Lurain, Guru Sonpavde, Abdul Rafeh Naqash - Journal of Clinical Oncology 2023 被引用: 69

  18. Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial

    著者: Padmanee Sharma, Margaret K. Callahan, Petri Bono, Joseph W. Kim, Pavlina Spiliopoulou, Emiliano Calvo, Rathi N. Pillai, Patrick A. Ott, Filippo de Braud, Michael A. Morse, Dung T. Le, Dirk Jaeger, Emily Chan, Chris Harbison, Chen-Sheng Lin, Marina Tschaika, Alex Azrilevich, Jonathan E. Rosenberg - The Lancet Oncology 2016 被引用: 685

  19. Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients

    著者: D. Scott Lim, Robert L. Smith, Linda D. Gillam, Firas Zahr, Scott Chadderdon, Raj Makkar, Ralph Stephan von Bardeleben, Robert Kipperman, Andrew N. Rassi, Molly Szerlip, Scott Goldman, Ignacio Inglessis‐Azuaje, Pradeep Yadav, Philipp Lurz, Charles J. Davidson, Mubashir Mumtaz, Hemal Gada, Saibal Kar, Susheel Kodali, Roger J. Laham, William Hiesinger, Neil Fam, Mirjam Keßler, William W. O’Neill, Brian Whisenant, Chad Kliger, Samir Kapadia, Volker Rudolph, Joseph Choo, James Hermiller, Michael A. Morse, Niklas Schofer, Sameer Gafoor, Azeem Latib, Konstantinos Koulogiannis, Leo Marcoff, Jörg Hausleiter - JACC: Cardiovascular Interventions 2022 被引用: 147

  20. The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients

    著者: Takuya Osada, Gabriel T. Chong, Robert L. Tansik, Timothy Hong, Neil L. Spector, Rakesh Kumar, Herbert I. Hurwitz, I K Dev, Andrew B. Nixon, H. Kim Lyerly, Timothy Clay, Michael A. Morse - Cancer Immunology Immunotherapy 2008 被引用: 310

  21. Where We Stand With Immunotherapy in Colorectal Cancer: Deficient Mismatch Repair, Proficient Mismatch Repair, and Toxicity Management

    著者: Michael J. Overman, Marc S. Ernstoff, Michael A. Morse - American Society of Clinical Oncology Educational Book 2018 被引用: 130

  22. Clinical trials of self-replicating RNA-based cancer vaccines

    著者: Michael A. Morse, Erika J. Crosby, Jeremy Force, Takuya Osada, Amy Hobeika, Zachary C. Hartman, Peter Berglund, Jonathan Smith, H. Kim Lyerly - Cancer Gene Therapy 2023 被引用: 54

  23. Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC Mutations

    著者: Takuya Osada, Minyong Chen, Xiao Yang, Ivan Spasojević, Jeffrey VanDeusen, David S. Hsu, Bryan M. Clary, Timothy M. Clay, Wei Chen, Michael A. Morse, H. Kim Lyerly - Cancer Research 2011 被引用: 266

  24. One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve

    著者: Brian Whisenant, Samir Kapadia, Mackram F. Eleid, Susheel Kodali, James M. McCabe, Amar Krishnaswamy, Michael A. Morse, Richard W. Smalling, Mark Reisman, Michael J. Mack, William W. O’Neill, Vinayak Bapat, Martin B. Leon, Charanjit S. Rihal, Raj Makkar, Mayra Guerrero - JAMA Cardiology 2020 被引用: 178